AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection for women, leveraging the transformative potential of AI and our proprietary biomarker technology. At the heart of this innovation is our GlycoLocate platform, a multi-omics approach powered by tumor marker gangliosides, lipids and proteins. This platform is setting a new gold standard in the quest for life-saving early cancer diagnostics. We are now advancing AKRIVIS GD™, a cutting-edge liquid biopsy test designed specifically for the early detection of ovarian cancer.
Company Details
- Employees
- 54
- Founded
- -
- Address
- Denver, Co 80221, Us
- Phone
- (617) 903-0350
- in****@****adx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aoadx.com
- Keywords
- Medical Devices, Diagnostics, Prognostics, Biotechnology, Sales, Commercialization, Regulatory, Licensing, Quality, FDA, IVD, CE IVDR, Ovarian Cancer, Women's Health, Cancer Diagnostics, Liquid Biopsy.
- HQ
- Denver, CO
Aoa Dx Questions
Aoa Dx's helpline number is (617) 903-0350
Aoa Dx's website is aoadx.com
Aoa Dx's LinkedIn profile is https://www.linkedin.com/company/aoadx
Aoa Dx has
54 employees.
View email and phone details for 54
employees at Aoa Dx.
Aoa Dx's industry is
Biotechnology Research
Aoa Dx's top competitors are
Celmatix Therapeutics,
Gameto,
Cayaba Care,
Evvy,
Oova,
Elektra Health,
Seven Starling,
Cofertility,
Enveda,
Twentyeight Health.
Aoa Dx's support email address is info@aoadx.com
Aoa Dx's categories are Biotechnology Research
Aoa Dx's founding year is 2020
